发明名称 New use
摘要 According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment. Suitable lower doses of pemirolast are least about 110 mg per day.
申请公布号 GB201518831(D0) 申请公布日期 2015.12.09
申请号 GB20150018831 申请日期 2015.10.23
申请人 RSPR PHARMA AB 发明人
分类号 主分类号
代理机构 代理人
主权项
地址